Skip to main content
Log in

Expression of 3β-hydroxysteroid dehydrogenase-5,4-en isomerase activity by infiltrating ductal human breast carcinoma in vitro

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

In order to determine whether human mammary tumors could contribute to progesterone synthesis from pregnenolone in breast cancer patients, homogenates of infiltrating ductal primary breast tumors at different stages of malignancy (Stages II and III) obtained from pre- and post-menopausal patients (n=7, age 37–66 years) were incubated with [7n-3H]pregnenolone as substrate. Controls were heated homogenates instead of fresh homogenates. With the use of reverse-isotope dilution analysis, [3H]progesterone was isolated and characterized. No such metabolite was evident in the control incubations of heat-denatured enzymes. The extent of enzymic conversion varied from 0.02 to 4.0%. The results reveal that activity of 3β-hydroxysteroid dehydrogenase-5,4-en isomerase that metabolizes pregnenolone to progesterone can be identified with the viable homogenates. It is suggested that there exists a potential for substantial progesterone synthesis in vivo. This conversion may be of considerable clinical, therapeutic, and pathophysiological significance in the patient with breast cancer. The biological impact of this conversion should be a high priority research objective.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Gunasegaram R, Peh KL, Loganath A, Ang LC, Chaing SC, Karim SMM, Ratnam SS: Cholesterol synthesizing enzymes in human breast cancer. IRCS Med Sci 10: 924, 1982

    Google Scholar 

  2. Gunasegaram R, Peh KL, Loganath A, James DT, Chew PCT, Ratnam SS: Metabolism in vitro of 26-14C cholesterol to 14CO2 in infiltrating duct human breast carcinoma. Singapore J Obstet Gynaecol 24: 121–124, 1993

    Google Scholar 

  3. Adams JB, Wong MSF: Desmolase activity of normal and malignant human breast tissue. J Endocr 44: 69–77, 1969

    Google Scholar 

  4. Adams JB, Wong MSF: Paraendocrine behaviour of human breast carcinoma: in vitro transformation of steroids to physiologically active hormones. J Endocr 41: 41–52, 1968

    Google Scholar 

  5. Gunasegaram R, Loganath A, Peh KL, Thiagaraj D, Kottegoda SR, Ratnam SS: Steroidogenic expression of δ8-3β-hydroxy pathway of androgen biosynthesis by human breast carcinoma. Ann Acad Med Singapore 15: 47–51, 1986

    Google Scholar 

  6. Jones D, Cameron EHD, Griffiths K, Gleave EN, Forrest APM: Steroid metabolism by human breast tumours. Biochem J 116: 919–921, 1970

    Google Scholar 

  7. James VHT, McNeill JM, Lai LC, Newton CJ, Ghilchik MW, Reed MJ: Aromatase activity in normal breast and breast tumor tissues: in vivo and in vitro studies. Steroids 50: 269–279, 1987

    Google Scholar 

  8. MacIndoe JH, Woods GR: Steroid metabolizing enzymes in human breast cancer cells. II. 5α-reductase, 3α-hydroxysteroid oxidoreductase, and 17β-hydroxysteroid oxidoreductase. Endocrinology 108: 1407–1413, 1981

    Google Scholar 

  9. Weisz J: In vitro assays of aromatase and their role in studies of estrogen formation in target tissues. Cancer Res Suppl 42: 3295s–3298s, 1982

    Google Scholar 

  10. Santen RJ, Santner SJ, Tilsen-Mallett N, Rosen HR, Samojlik E, Veldhuis JD: In vivo and in vitro pharmacological studies of aminoglutethimide as an aromatase inhibitor. Cancer Res Suppl 42: 3353s–3359s, 1982

    Google Scholar 

  11. Osawa Y, Tochigi B, Higashiyama T, Yarborough C, Nakamura T, Yamamoto T: Multiple forms of aromatase and response of breast cancer aromatase to antiplacental aromatase II antibodies. Cancer Res Suppl 42: 3299s–3306s, 1982

    Google Scholar 

  12. Coldham NG, James VHT: A possible mechanism for increased breast cell proliferation by progestins through increased reductive 17β-hydroxysteroid dehydrogenase activity. Int J Cancer 45: 174–178, 1990

    Google Scholar 

  13. Pasqualini JR, Schatz B, Varin C, Nguyen B-L: Recent data on estrogen sulfatase and sulfotransferase activities in human breast cancer. J Steroid Biochem 41: 323–329, 1992

    Google Scholar 

  14. Bresciani F: Ovarian steroid control of cell proliferation in the mammary gland and cancer. In: Basic Actions of Sex Steroids on Target Organs. Karger Publishing Company, Basel, 1971, p 130

    Google Scholar 

  15. McManus MJ, Welsch CW: The effect of estrogen, progesterone, thyroxine and human placental lactogen on DNA synthesis of human breast ductal epithelium maintained in athymic nude mice. Cancer 54: 1920–1927, 1984

    Google Scholar 

  16. Bloom HJG: Prognosis in carcinoma of the breast. Br J Cancer 4: 259–288, 1950

    Google Scholar 

  17. Gunasegaram R, Peh KL, Loganath A, Chow WP, Chew PCT, Ratnam SS: A comparative study of progesterone synthesis by term human fetal amnion and chorion. J Perinat Med 23: 371–377, 1995

    Google Scholar 

  18. Power SGA, Patrick JE, Carson GD, Challis JRG: The fetal membranes as a possible source of progesterone in the amniotic and allantoic fluids of pregnant sheep. Endocrinology 110: 481–486, 1982

    Google Scholar 

  19. Peh KL, Gunasegaram R, Loganath A, Cheah E, Ratnam SS: Testosterone synthesis by infiltrating ductal human breast carcinoma in vitro. Med Sci Res 15: 1467–1468, 1987

    Google Scholar 

  20. Lanthier A, Patwardhan VV: Sex steroids and 5-en-3β-hydroxysteroids in specific regions of the human brain and cranial nerves. J Steroid Biochem 25: 445–449, 1985

    Google Scholar 

  21. Lacroix C, Fiett J, Benais J-P, Gueux B, Bonete R, Villette J-M, Gourmel B, Dreux C: Simultaneous radioimmunoassay of progesterone, androst-4-enedione, pregnenolone, dehydroepiandrosterone and 17-hydroxyprogesterone in specific regions of human brain. J Steroid Biochem 28: 317–325, 1987

    Google Scholar 

  22. Morfin R, Young J, Corpéchot C, Egestad B, Sjovall J, Baulieu E-E: Neurosteroids: Pregnenolone in human sciatic nerves. Proc Natl Acad Sci USA 89: 6790–6793, 1992

    Google Scholar 

  23. Gunasegaram R, Peh KL, Loganath A, Ang LC, Thiagaraj D, Kottegoda SR, Ratnam SS: An imbalance in concentration of gonadotrophins in infiltrating ductal human breast carcinoma. IRCS Med Sci 12: 711–712, 1984

    Google Scholar 

  24. Gunasegaram R, Peh KL, Loganath A, Ang LC, Thiagaraj D, Kottegoda SR, Ratnam SS: Inappropriate luteinizing hormone concentration in human breast cancer. Aust NZ J Surg 55: 127–131, 1985

    Google Scholar 

  25. Loganath A, Peh KL, Gunasegaram R, Thiagaraj D, Cheah E, Kottegoda SR, Ratnam SS: Comparison of AFP and β-hCG levels in infiltrating duct mammary carcinoma at different stages of malignancy. Pathology 20: 275–278, 1988

    Google Scholar 

  26. Imagawa W, Tomooka Y, Hamamoto S, Nandi S: Stimulation of mammary epithelial cells growth in vitro: interaction of epidermal growth factor and mammogenic hormones. Endocrinology 116: 1514–1524, 1985

    Google Scholar 

  27. Haslam SZ: Progesterone effects and deoxyribonucleic acid synthesis in normal mouse mammary glands. Endocrinology 122: 464–470, 1988

    Google Scholar 

  28. Masters JRW, Drife JO, Scarisbrick JJ: Cyclic variation of DNA synthesis in human breast epithelium. J Natl Cancer Inst 58: 1263–1265, 1977

    Google Scholar 

  29. Michna H, Nishino Y, Schneider MR, Louton T, El Etreby MF: A bioassay for the evaluation of antiproliferative potencies of progesterone antagonists. J Steroid Biochem Mol Biol 38: 359–365, 1991

    Google Scholar 

  30. Mauvais-Jarvis P, Kuttenn F, Gompel A: Antiestrogen action of progesterone in breast tissue. Breast Cancer Res Treat 8: 179–188, 1986

    Google Scholar 

  31. Bardon S, Vignon F, Chalbos D, Rochefort H: RU 486, a progestin and glucocorticoid antagonist inhibits the growth of breast cancer cells via progesterone receptor. J Clin Endocrinol Metab 60: 692–697, 1985

    Google Scholar 

  32. Sutherland RL, Hall RE, Pang GYN, Musgrove EA, Clarke CL: Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells. Cancer Res 48: 5084–5091, 1988

    Google Scholar 

  33. Horwitz KB: The antiprogestin RU 486; Receptor-mediated progestin versus antiprogestin actions screened in estrogen-insensitive T47Dco human breast cancer cells. Endocrinology 116: 2236–2245, 1985

    Google Scholar 

  34. Murphy LC, Murphy LJ, Dubik D, Bell GI, Shiu RPC: Epidermal growth factor gene expression in human breast cancer cells: regulation of expression by progestins. Cancer Res 48: 4555–4560, 1988

    Google Scholar 

  35. Gompel A, Malet C, Spritzer P, Lalardrie J-P, Kuttenn F, Mauvis-Jarvis P: Progestin effect on cell proliferation and 17β-hydroxysteroid dehydrogenase activity in normal human breast cells in culture. J Clin Endocrinol Metab 63: 1174–1180, 1986

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gunasegaram, R., Peh, K., Loganath, A. et al. Expression of 3β-hydroxysteroid dehydrogenase-5,4-en isomerase activity by infiltrating ductal human breast carcinoma in vitro. Breast Cancer Res Treat 50, 117–123 (1998). https://doi.org/10.1023/A:1006009031839

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006009031839

Navigation